Interim report, May–July 2019/20
Very strong order intake kick-starts the year The year got off to a great start, demonstrating that innovation enables growth, with an increase in order intake by 32 percent. Underlying profitability increased, benefitting from higher net sales and improved gross margin. With this very encouraging quarter, we’re in a strong position to continue creating value and strengthening our leadership in precision radiation medicine. Richard HausmannPresident and CEO First quarter• Gross order intake amounted to SEK 4,390 M (3,174), corresponding to a 32 percent organic growth.• Net